177lu-psma-617
novartis
['#vision', 'prostate', 'novartis']
attending #asco23 and interested in learning about the latest science in tumor dosimetry in patients with metastatic castration-resistant prostate cancer? check out abstract no. 5046 on sat, june 3 from 8 to 11 am cdt for the latest novartis presentation from the #vision study
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu